Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | CDK12 |
| Variant | K1021* |
| Impact List | nonsense |
| Protein Effect | loss of function - predicted |
| Gene Variant Descriptions | CDK12 K1021* results in a premature truncation of the Cdk12 protein at amino acid 1021 of 1490 (UniProt.org). K1021* results in loss of binding to Ccnk in cell culture (PMID: 39321214), and therefore, is predicted to lead to a loss of Cdk12 protein function. |
| Associated Drug Resistance | |
| Category Variants Paths |
CDK12 mutant CDK12 inact mut CDK12 K1021* |
| Transcript | NM_016507.4 |
| gDNA | chr17:g.39520053A>T |
| cDNA | c.3061A>T |
| Protein | p.K1021* |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| XM_047436287.1 | chr17:g.39520053A>T | c.3061A>T | p.K1021* | RefSeq | GRCh38/hg38 |
| XM_047436260.1 | chr17:g.39520053A>T | c.3061A>T | p.K1021* | RefSeq | GRCh38/hg38 |
| XM_047436261.1 | chr17:g.39520053A>T | c.3061A>T | p.K1021* | RefSeq | GRCh38/hg38 |
| XM_047436272.1 | chr17:g.39520053A>T | c.3061A>T | p.K1021* | RefSeq | GRCh38/hg38 |
| XM_047436265.1 | chr17:g.39520053A>T | c.3061A>T | p.K1021* | RefSeq | GRCh38/hg38 |
| XM_047436288.1 | chr17:g.39520053A>T | c.3061A>T | p.K1021* | RefSeq | GRCh38/hg38 |
| XM_047436276.1 | chr17:g.39520053A>T | c.3061A>T | p.K1021* | RefSeq | GRCh38/hg38 |
| XM_011524893.3 | chr17:g.39520053A>T | c.3061A>T | p.K1021* | RefSeq | GRCh38/hg38 |
| XM_011524895.3 | chr17:g.39520053A>T | c.3061A>T | p.K1021* | RefSeq | GRCh38/hg38 |
| XM_047436268.1 | chr17:g.39520053A>T | c.3061A>T | p.K1021* | RefSeq | GRCh38/hg38 |
| XM_047436274.1 | chr17:g.39520053A>T | c.3061A>T | p.K1021* | RefSeq | GRCh38/hg38 |
| XM_047436259.1 | chr17:g.39520053A>T | c.3061A>T | p.K1021* | RefSeq | GRCh38/hg38 |
| NM_015083.4 | chr17:g.39520053A>T | c.3061A>T | p.K1021* | RefSeq | GRCh38/hg38 |
| XM_011524894.3 | chr17:g.39520053A>T | c.3061A>T | p.K1021* | RefSeq | GRCh38/hg38 |
| XM_047436273.1 | chr17:g.39520053A>T | c.3061A>T | p.K1021* | RefSeq | GRCh38/hg38 |
| XM_047436270.1 | chr17:g.39520053A>T | c.3061A>T | p.K1021* | RefSeq | GRCh38/hg38 |
| XM_047436279.1 | chr17:g.39520053A>T | c.3061A>T | p.K1021* | RefSeq | GRCh38/hg38 |
| XM_011524907.3 | chr17:g.39520053A>T | c.3061A>T | p.K1021* | RefSeq | GRCh38/hg38 |
| XM_011524898.3 | chr17:g.39520053A>T | c.3061A>T | p.K1021* | RefSeq | GRCh38/hg38 |
| XM_047436266.1 | chr17:g.39520053A>T | c.3061A>T | p.K1021* | RefSeq | GRCh38/hg38 |
| NM_016507.4 | chr17:g.39520053A>T | c.3061A>T | p.K1021* | RefSeq | GRCh38/hg38 |
| XM_047436278.1 | chr17:g.39520053A>T | c.3061A>T | p.K1021* | RefSeq | GRCh38/hg38 |
| XM_047436258.1 | chr17:g.39520053A>T | c.3061A>T | p.K1021* | RefSeq | GRCh38/hg38 |
| XM_047436275.1 | chr17:g.39520053A>T | c.3061A>T | p.K1021* | RefSeq | GRCh38/hg38 |
| XM_047436256.1 | chr17:g.39520053A>T | c.3061A>T | p.K1021* | RefSeq | GRCh38/hg38 |
| XM_011524897.3 | chr17:g.39520053A>T | c.3061A>T | p.K1021* | RefSeq | GRCh38/hg38 |
| XM_047436255.1 | chr17:g.39520053A>T | c.3061A>T | p.K1021* | RefSeq | GRCh38/hg38 |
| XM_047436269.1 | chr17:g.39520053A>T | c.3061A>T | p.K1021* | RefSeq | GRCh38/hg38 |
| XM_011524906.3 | chr17:g.39520053A>T | c.3061A>T | p.K1021* | RefSeq | GRCh38/hg38 |
| XM_047436257.1 | chr17:g.39520053A>T | c.3061A>T | p.K1021* | RefSeq | GRCh38/hg38 |
| XM_047436267.1 | chr17:g.39520053A>T | c.3061A>T | p.K1021* | RefSeq | GRCh38/hg38 |
| XM_047436277.1 | chr17:g.39520053A>T | c.3061A>T | p.K1021* | RefSeq | GRCh38/hg38 |
| XM_047436289.1 | chr17:g.39520053A>T | c.3061A>T | p.K1021* | RefSeq | GRCh38/hg38 |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|